Prevalence of Chronic Backpain after COVID-19 Astra Zeneca and Pfizer/BioNTech Vaccines in Sultanate of Oman: A Survey-based Study

Abstract

Introduction: Covid-19 vaccine is known to cause a variety of side effects. Low back pain has been reported to be associated with at least one of the COVID-19 vaccines. Objectives: The current study investigated the prevalence of chronic back pain in individuals vaccinated with AstraZeneca and Pfizer in Sultanate of Oman. Methods: This cross-sectional observational survey-based study was conducted among COVID-19 AstraZeneca and Pfizer/BioNTech vaccinated individuals in Sultanate of Oman. Two hundred participants were involved in the study. Chi square was used to analyse the association between categorical data. Data were analysed using SPSS (29th release). Results: The prevalence of back pain among individuals vaccinated with AstraZeneca and Pfizer, was 36%. Females were more commonly affected by the back pain, especially in the 4th decade of life. Conclusion: AstraZeneca and Pfizer is be associated with back pain, especially in females. Possible explanations require further investigations.